NTF3 and hepatocellular carcinoma: The results showed that NTF3 was downregulated in 9 of 15 HCC tissues, PSMD14 was upregulated in 11 of 15 HCC tissues, and SORT1 was upregulated in 9 of 15 HCC tissues (Fig. 9C-a–c).